[en] The interaction of diazepine analogues like clozapine or olanzapine with D2 receptor was greatly affected by a mixture of HRP/H2O2 known to induce the formation of nitrenium ion. Unlike diazepine derivatives, the oxidative mixture had low impact on the affinity of oxa- and thiazepine derivatives such as loxapine, clothiapine or JL13 for the D2 receptor. Molecular docking simulations revealed a huge difference between the mode of interaction of clozapine nitrenium ion and the parent drug. Electronic and geometric changes of the tricyclic ring system caused by the oxidation appeared to prevent the compound finding the correct binding mode and could therefore explain the difference observed in binding affinities.
Centre/Unité de recherche :
Laboratory of Medicinal Chemistry, Drug Research Center
J-F Liégeois A Mouithys-Mickalad J Bruhwyler J Delarge C Petit J-M Kauffmann M Lamy 1997 Biochem Biophys Res Commun 238 252 255 10.1006/bbrc.1997.7270 (Pubitemid 27453310)
J Uetrecht N Zahid A Tehim J Mimfu S Rakhit 1997 Chem-Biol Interact 104 117 129 1:CAS:528:DyaK2sXkt12ksrw%3D 10.1016/S0009-2797(97)00017-3 (Pubitemid 27263369)
JR Bunzow HHM Van Tol DK Grandy P Albert J Salon M Christie CA Machida KA Neve O Civelli 1988 Nature 336 783 787 1:CAS:528:DyaL1MXkvFWntLo%3D 10.1038/336783a0 (Pubitemid 19014439)
G Jones P Willet RC Glen AR Leach R Taylor 1997 J Mol Biol 267 727 748 1:CAS:528:DyaK2sXis1KntLo%3D 10.1006/jmbi.1996.0897 (Pubitemid 27170693)
A Mansour F Meng JH Meador-Woodru LP Taylor O Civelli H Akil 1992 Eur J Pharmacol 227 205 214 1:CAS:528:DyaK38Xmt1KntLc%3D 10.1016/0922-4106(92)90129-J
W Heiden G Moeckel JA Brickmann 1993 J Comput Aided Mol Des 7 503 514 1:CAS:528:DyaK2cXivFent7c%3D 10.1007/BF00124359
A Jegouzo B Gressier B Frimat C Brunet T Dine M Luyckx M Kouach M Cazin JC Cazin 1999 Fundam Clin Pharmacol 13 113 119 1:CAS:528:DyaK1MXpvFWlsw%3D%3D 10.1111/j.1472-8206.1999.tb00329.x
DP Williams CJL O'Donnell JL Maggs JS Leeder J Uetrecht M Pirmohamed BK Park 2003 Chem Res Toxicol 16 1359 1364 1:CAS:528:DC%2BD3sXotFCmsL8%3D 10.1021/tx034035z (Pubitemid 37315224)
J Selent L Lopez F Sanz M Pastor 2008 ChemMedChem 3 1194 1198 1:CAS:528:DC%2BD1cXhtVOhs7bK 10.1002/cmdc.200800074
E Hjerde SG Dahl I Sylte 2005 Eur J Med Chem 40 185 194 1:CAS:528:DC%2BD2MXht1Gjsr4%3D 10.1016/j.ejmech.2004.10.010 (Pubitemid 40203159)
MY Kalani N Vaidehi SE Hall RJ Trabanino PL Freddolino MA Kalani WB Floriano VW Kam WA Goddard III 2004 Proc Natl Acad Sci USA 101 3815 3820 10.1073/pnas.0400100101 (Pubitemid 38381061)
PA Sims CF Wong D Vuga JA McCammon BM Sefton 2005 J Comput Chem 26 668 681 1:CAS:528:DC%2BD2MXjsF2msrY%3D 10.1002/jcc.20207 (Pubitemid 40666217)
N Shimokhina A Bronowska SW Homans 2006 Angew Chem Int Ed Engl 45 6374 6376 1:CAS:528:DC%2BD28XhtVKmt73I 10.1002/anie.200602227 (Pubitemid 44483868)
C Browning E Martin C Loch JM Wurtz D Moras RH Stote AP Dejaegere IM Billas 2007 J Biol Chem 282 32924 32934 1:CAS:528:DC%2BD2sXht1CltbfF 10.1074/jbc.M705559200 (Pubitemid 350159267)
NR Syme C Dennis A Bronowska GC Paesen SW Homans 2010 J Am Chem Soc 132 8682 8689 1:CAS:528:DC%2BC3cXntVCnsbc%3D 10.1021/ja101362u
MS Patole A Swaroop T Ramasarma 1986 J Neurochem 47 1 8 1:CAS:528:DyaL28XkslCnurs%3D 10.1111/j.1471-4159.1986.tb02823.x
L Bao MV Avshalumov JC Patel CR Lee EW Miller CJ Chang ME Rice 2009 J Neurosci 29 9002 9010 1:CAS:528:DC%2BD1MXovFegur0%3D 10.1523/JNEUROSCI.1706-09. 2009
BJ Tabner S Turnbull OM El-Agnaf D Allsop 2002 Free Radic Biol Med 32 1076 1083 1:CAS:528:DC%2BD38XjvVehurg%3D 10.1016/S0891-5849(02)00801-8 (Pubitemid 34603345)
MV Avshalumov L Bao JC Patel ME Rice 2007 Antioxid Redox Signal 9 219 231 1:CAS:528:DC%2BD28Xht1yis7bI 10.1089/ars.2007.9.219 (Pubitemid 46105421)
DL Lefkowitz SS Lefkowitz 2008 Free Rad Biol Med 45 726 731 1:CAS:528:DC%2BD1cXpslWrsLY%3D 10.1016/j.freeradbiomed.2008.05.021
A Schotte PF Janssen W Gommeren WH Luyten P Van Gompel AS Lesage K De Loore JE Leysen 1996 Psychopharmacology (Berl) 124 57 73 1:CAS:528: DyaK28XjsFGktLk%3D 10.1007/BF02245606 (Pubitemid 26112775)
R Foster A Kandanearatchi C Beasley B Williams N Khan MK Fagerhol IP Everall 2006 Eur J Neurosci 24 3561 3566 10.1111/j.1460-9568.2006.05219.x (Pubitemid 44952621)
J Doorduin EF de Vries AT Willemsen JC de Groot RA Dierckx HC Klein 2009 J Nucl Med 50 1801 1807 10.2967/jnumed.109.066647
BK Bitanihirwe TU Woo 2011 Neurosci Biobehav Rev 35 878 893 1:CAS:528:DC%2BC3cXhsFCrurvK 10.1016/j.neubiorev.2010.10.008
RX Santos S Cardoso S Silva S Correia C Carvalho J Crisostomo L Rodrigues C Amaral T Louro P Matafome MS Santos T Proença AL Duarte R Seiça PI Moreira 2009 J Food Sci 74 H8 H14 1:CAS:528:DC%2BD1MXhs1Ojsbc%3D 10.1111/j.1750-3841.2008.00982.x